1 / 14

Leukapheresis Devices Market Analysis (2020-2027)

Read here the market research report on the u201cLeukapheresis Marketu201d published by CMI team

kunalbhuta
Download Presentation

Leukapheresis Devices Market Analysis (2020-2027)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. LEUKAPHERESIS DEVICES MARKET ANALYSIS (2020-2027) • Leukapheresis Market, by Device Type (Apheresis Devices, Leukapheresis Columns & Cell Separators, Leukoreduction Filters, and Leukapheresis Disposables), By Application (Research Applications and Therapeutic Applications), by End User (Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Blood Component Providers and Blood Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

  3. Leukapheresis is a procedure used to treat chronic lymphocytic leukemia (CLL) or patients with very high white blood cell counts. Leukemia starts in early forms of blood cells, usually white blood cells or leucocytes, which helps to fight against infections caused by foreign particles. • The leukapheresis devices market is estimated to be valued at US$ 22.32 million in 2020 and is expected to exhibit a CAGR of 7.6% during the forecast period (2020-2027).

  4. Figure 1: Leukapheresis Devices Market Share (%) Analysis, By Region, 2020

  5. Increasing incidence of leukemia and number of blood donations are expected to drive the market growth over the forecast period • According to the International Agency for Research on Cancer (IARC), in 2018, around 437,033 cases of leukemia were registered and 309,006 deaths occurred due to leukemia, globally. • The need for blood and blood products is increasing every year in many countries - particularly low and middle income countries. Transfusion of blood and blood products help patients suffering from life-threatening conditions to live longer and maintain a higher quality of life, and it supports complex medical and surgical procedures. • According to the American National Red Cross 2020, around 21 million blood components are transfused each year in the U.S.

  6. Leukapheresis Market- Restraints However, high cost associated with apheresis procedure and devices are major factors that hinder growth of the market. For instance, in the U.S., the cost of an apheresis procedure is around US$ 2,500 per treatment, which is very high. Furthermore, in India, the apheresis machine costs US$ 23,459 and there is an apheresis kit, which is required for separating components costing around US$ 134, which is very costly for low-income individuals to afford.

  7. Leukapheresis Market– Regional Analysis • North America accounted for the largest share in the leukapheresis devices market in 2019, owing to increasing prevalence and incidence of leukemia in this region. According to Leukemia and Lymphoma Society (LLS), in 2019, around 61,780 people were diagnosed with leukemia. According to Leukemia and Lymphoma Society and American Cancer Society, from 2011-2015, in the U.S., leukemia was the sixth most common cause of cancer death in both men and women. • Furthermore, Asia Pacific is expected to witness the fastest growth during the forecast period. Owing to increasing geriatric population and health expenditure. For instance, according to the Population Census 2011, there were around 104 million elderly persons (aged 60 years or above) in India; 53 million females and 51 million males, and is expected to reach 173 million by 2026 in India.

  8. Figure 2: Leukapheresis Devices Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

  9. Leukapheresis Market- Competitive Landscape • Key players operating in the leukapheresis devices market include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, and Key Biologics, LLC.

  10. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/leukapheresis-devices-market-4142

  11. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  12. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related